Line Melgaard

510 total citations
14 papers, 362 citations indexed

About

Line Melgaard is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Line Melgaard has authored 14 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Line Melgaard's work include Atrial Fibrillation Management and Outcomes (13 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Line Melgaard is often cited by papers focused on Atrial Fibrillation Management and Outcomes (13 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Line Melgaard collaborates with scholars based in Denmark, United Kingdom and United States. Line Melgaard's co-authors include Torben Bjerregaard Larsen, Gregory Y.H. Lip, Lars Hvilsted Rasmussen, Anders Gorst‐Rasmussen, Deirdre A. Lane, Flemming Skjøth, Peter Brønnum Nielsen, Thure Filskov Overvad, Peter Søgaard and Jeppe Hagstrup Christensen and has published in prestigious journals such as JAMA, PLoS ONE and Stroke.

In The Last Decade

Line Melgaard

14 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Line Melgaard Denmark	8	303	79	76	47	27	14	362
Yee Cheng Lau United Kingdom	8	295 1.0×	97 1.2×	46 0.6×	31 0.7×	52 1.9×	23	365
Anna Gundlund Denmark	11	436 1.4×	97 1.2×	36 0.5×	69 1.5×	48 1.8×	25	475
António Leitão Marques Portugal	9	198 0.7×	81 1.0×	53 0.7×	27 0.6×	55 2.0×	36	297
Dae In Lee South Korea	12	342 1.1×	43 0.5×	23 0.3×	42 0.9×	47 1.7×	69	416
Ling Kuo Taiwan	11	333 1.1×	43 0.5×	47 0.6×	32 0.7×	25 0.9×	69	397
D. Poli Italy	8	186 0.6×	113 1.4×	64 0.8×	21 0.4×	45 1.7×	19	353
Dritan Poçi Sweden	11	673 2.2×	64 0.8×	65 0.9×	77 1.6×	57 2.1×	23	720
Sonia Azzopardi Australia	12	918 3.0×	28 0.4×	58 0.8×	70 1.5×	36 1.3×	20	968
Younos Abdulsattar United States	9	283 0.9×	62 0.8×	47 0.6×	16 0.3×	22 0.8×	14	338
Shamik Aikat United States	9	231 0.8×	40 0.5×	35 0.5×	28 0.6×	45 1.7×	14	303

Countries citing papers authored by Line Melgaard

Since Specialization

Citations

This map shows the geographic impact of Line Melgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Melgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Melgaard more than expected).

Fields of papers citing papers by Line Melgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Melgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Melgaard. The network helps show where Line Melgaard may publish in the future.

Co-authorship network of co-authors of Line Melgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Line Melgaard. A scholar is included among the top collaborators of Line Melgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Melgaard. Line Melgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Melgaard, Line, Thure Filskov Overvad, Thomas Decker Christensen, et al.. (2021). Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis. Journal of the American Heart Association. 10(23). e022628–e022628. 6 indexed citations

Melgaard, Line, et al.. (2020). Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease. JACC. Clinical electrophysiology. 6(13). 1672–1682. 2 indexed citations

Melgaard, Line, et al.. (2020). Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: a descriptive nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 7(FI1). f101–f110. 15 indexed citations

Melgaard, Line, et al.. (2020). Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study. International Journal of Clinical Practice. 74(10). e13589–e13589. 7 indexed citations

Melgaard, Line, et al.. (2019). 210Predictors of thromboembolism in patients with atrial fibrillation and valvular heart disease according to the EHRA classification: beyond mitral stenosis and mechanical prosthetic heart valves. European Heart Journal. 40(Supplement_1). 1 indexed citations

Søgaard, Mette, Line Melgaard, Deirdre A. Lane, et al.. (2019). Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study. BMJ Open. 9(5). e026159–e026159. 7 indexed citations

Melgaard, Line, Peter Brønnum Nielsen, Thure Filskov Overvad, et al.. (2018). Sex differences in risk of incident venous thromboembolism in heart failure patients. Clinical Research in Cardiology. 108(1). 101–109. 16 indexed citations

Melgaard, Line, Thure Filskov Overvad, Flemming Skjøth, et al.. (2018). Risk of Stroke and Bleeding in Patients with Heart Failure and Chronic Kidney Disease: A Nationwide Cohort Study. ESC Heart Failure. 5(2). 319–326. 6 indexed citations

Lip, Gregory Y.H., et al.. (2018). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating ‘valvular heart disease’ in a nationwide cohort study. EP Europace. 21(1). 33–40. 19 indexed citations

10.

Melgaard, Line, Anders Gorst‐Rasmussen, Lars Hvilsted Rasmussen, Gregory Y.H. Lip, & Torben Bjerregaard Larsen. (2016). Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study. PLoS ONE. 11(3). e0152269–e0152269. 6 indexed citations

11.

Melgaard, Line, Anders Gorst‐Rasmussen, Peter Søgaard, et al.. (2016). Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation. International Journal of Cardiology. 209. 1–6. 13 indexed citations

12.

Melgaard, Line, Anders Gorst‐Rasmussen, Deirdre A. Lane, et al.. (2015). Assessment of the CHA₂DS₂-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA. 314(10). 1030–1030. 231 indexed citations

13.

Melgaard, Line, Anders Gorst‐Rasmussen, Gregory Y.H. Lip, Lars Hvilsted Rasmussen, & Torben Bjerregaard Larsen. (2014). Female sex is associated with a lower risk of stroke in patients with heart failure. American Heart Journal. 169(3). 396–403.e2. 5 indexed citations

14.

Melgaard, Line, Lars Hvilsted Rasmussen, Flemming Skjøth, Gregory Y.H. Lip, & Torben Bjerregaard Larsen. (2014). Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation. Stroke. 45(5). 1331–1337. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact